Case Study

Modular Bioprocess Platform Gives CMO Maximum Flexibility

Source: Thermo Fisher Scientific
Bioprocess

Pharmaceutical companies are increasingly outsourcing product production to contract manufacturing organizations (CMOs). Doing so enables them to focus more of their resources on developing innovative new products and less on non-core, commodity activities, such as manufacturing. While this has been a boon for CMOs, it also creates new challenges as both their client base and related production demands rapidly diversify. Just staying on top of it all can be a big job.